Reporting the novel synthetic cathinone 5-PPDI through its analytical characterization by mass spectrometry and nuclear magnetic resonance
Visualitza/
Impacte
Scholar |
Altres documents de l'autoria: Fabregat-Safont, David; Carbón, Xoán; Gil Iladanosa, Cristina; Ventura, Mireia; Sancho, Juan V; Hernandez, Felix; Ibáñez, Maria
Metadades
Mostra el registre complet de l'elementcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/33596
comunitat-uji-handle3:10234/33597
comunitat-uji-handle4:
INVESTIGACIONAquest recurs és restringit
https://doi.org/10.1007/s11419-018-0422-0 |
Metadades
Títol
Reporting the novel synthetic cathinone 5-PPDI through its analytical characterization by mass spectrometry and nuclear magnetic resonanceAutoria
Data de publicació
2018-07Editor
SpringerCita bibliogràfica
FABREGAT-SAFONT, David; CARBÓN, Xoán; GIL ILADANOSA, Cristina; VENTURA, Mireia; SANCHO LLOPIS, Juan Vicente; HERNÁNDEZ HERNÁNDEZ, Félix; IBÁÑEZ MARTÍNEZ, María (2018). Reporting the novel synthetic cathinone 5-PPDI through its analytical characterization by mass spectrometry and nuclear magnetic resonance. Forensic Toxicology, v. 36, issue 2, p. 447-457Tipus de document
info:eu-repo/semantics/articleVersió de l'editorial
https://link.springer.com/article/10.1007/s11419-018-0422-0Versió
info:eu-repo/semantics/publishedVersionParaules clau / Matèries
Resum
Introduction:
User
surveys
indicate
that
expectations
of
higher
drug
purity
are
a
key
reason
for
cryptomarket
use.
In
2014–2015,
Spain’s
NGO
Energy
Control
conducted
a
1-year
pilot
project ... [+]
Introduction:
User
surveys
indicate
that
expectations
of
higher
drug
purity
are
a
key
reason
for
cryptomarket
use.
In
2014–2015,
Spain’s
NGO
Energy
Control
conducted
a
1-year
pilot
project
to
provide
a
testing
service
to
cryptomarket
drug
users
using
the
Transnational
European
Drug
Information
(TEDI)
guidelines.
In
this
paper,
we
present
content
and
purity
data
from
the
trial.
Methods:
219
samples
were
analyzed
by
gas
chromatography
associated
with
mass
spectrometry
(GC/
MS).
Users
were
asked
to
report
what
substance
they
allegedly
purchased.
Results:
40
different
advertised
substances
were
reported,
although
77.6%
were
common
recreational
drugs
(cocaine,
MDMA,
amphetamines,
LSD,
ketamine,
cannabis).
In
200
samples
(91.3%),
the
main
result
of
analysis
matched
the
advertised
substance.
Where
the
advertised
compound
was
detected,
purity
levels
(m
SD)
were:
cocaine
71.6
19.4%;
MDMA
(crystal)
88.3
1.4%;
MDMA
(pills)
133.3
38.4
mg;
Amphetamine
(speed)
51.3
33.9%;
LSD
123.6
40.5
m
g;
Cannabis
resin
THC:
16.5
7.5%
CBD:
3.4
1.5%;
Ketamine
71.3
38.4%.
39.8%
of
cocaine
samples
contained
the
adulterant
levamisole
(11.6
8%).
No
adulterants
were
found
in
MDMA
and
LSD
samples.
Discussion:
The
largest
collection
of
test
results
from
drug
samples
delivered
from
cryptomarkets
are
reported
in
this
study.
Most
substances
contained
the
advertised
ingredient
and
most
samples
were
of
high
purity.
The
representativeness
of
these
results
is
unknown [-]
Publicat a
Forensic Toxicology (2018), v. 36, issue 2Proyecto de investigación
National Health & Medical Research Council Early Career Researcher Fellowship (APP1070140).Drets d'accés
http://rightsstatements.org/vocab/CNE/1.0/
info:eu-repo/semantics/restrictedAccess
info:eu-repo/semantics/restrictedAccess
Apareix a les col.leccions
- IUPA_Articles [306]